Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
Refine your Search
|
Title
|
Publication Date
|
Price
|
Relevance
|
Daiichi Sankyo Company, Ltd – Product Pipeline Review
H2 2011
|
Nov 2011 |
£315 |
100% |
Daewoong Pharmaceutical Co., Ltd. – Product Pipeline Review
H2 2011
|
Nov 2011 |
£315 |
92% |
Kyowa Hakko Kirin Co., Ltd. – Product Pipeline Review
H2 2011
|
Nov 2011 |
£315 |
89% |
|
Acute Coronary Syndrome
|
Apr 2010 |
£2,180 |
87% |
|
Cardiovascular Drugs
|
Apr 2010 |
£2,815 |
86% |
Maruho Co.,Ltd. – Product Pipeline Review
H2 2011
|
Dec 2011 |
£315 |
85% |
Hypertension - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
85% |
|
Anti-Hypertensive Drugs
|
Feb 2010 |
£2,500 |
84% |
|
Antibacterial Drugs
|
Apr 2010 |
£2,500 |
83% |
|
Imaging Agents
|
Feb 2011 |
£2,845 |
83% |
Benign Prostatic Hyperplasia - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
80% |
Chronic Pain - Pipeline Review
H2 2011
|
Aug 2011 |
£315 |
78% |
Santen Pharmaceutical Co., Ltd. – Product Pipeline Review
H2 2011
|
Nov 2011 |
£315 |
78% |
Colorectal Cancer - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
78% |
Gastric Cancer - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
78% |
Ovarian Cancer - Pipeline Review
H1 2012
|
Jan 2012 |
£325 |
77% |
Alzheimer's Disease - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
77% |
Multiple Sclerosis - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
77% |
Atopic Dermatitis (Eczema) - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
77% |
Type 2 Diabetes - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
77% |
Hypertension - Pipeline Review
Q1 2011
|
Feb 2011 |
£315 |
77% |
Non-Small Cell Lung Cancer - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
77% |
Hepatocellular Carcinoma - Pipeline Review
H1 2012
|
Jan 2012 |
£325 |
77% |
Obesity - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
77% |
The Indian Pharmaceutical Industry
New strategies in a changing world
|
Jan 2012 |
£995 |
77% |
Influenza - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
76% |
Atrial Fibrillation - Pipeline Review
H2 2011
|
Sep 2011 |
£315 |
76% |
Astrocytoma - Pipeline Review
H2 2011
|
Aug 2011 |
£315 |
76% |
Liver Cancer - Pipeline Review
H1 2012
|
Jan 2012 |
£325 |
76% |
Parkinson's Disease - Pipeline Review
H1 2012
|
Jan 2012 |
£325 |
76% |
